A lot of good can come when celebrities speak out about their medical diagnoses. However, these celebs say they initially ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use ...

For an esthetic salon, deciding to forgo a treatment even when a reservation is booked is not a very pleasant decision. The ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...

Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...

BRINSUPRI is the first and only approved and commercially available treatment for patients diagnosed with NCFB in Japan. The Japan Ministry of Health, Labour, and Welfare (MHLW) approved BRINSUPRI in ...

WHEN Dora Winslet woke up with blood on her pillow one day, she assumed she had scratched herself in her sleep. The ...

Cancer drugs can cause skin to thin, bruise and crack, so here are items, routines and adaptations experts suggest to ...

Durham-based Priovant Therapeutics has received U.S. Food and Drug Administration (FDA) approval for Lisraya (brepocitinib) 30 mg for the treatment of adults with dermatomyositis. Lisraya is a ...